ShilpaShahaniMD

PubMed

• Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-ce...
  Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L Locke, Tanya Siddiqi, Caron A Jacobson, Sairah Ahmed, David B Miklos, Yi Lin, Brian T Hill, Armin Ghobadi, S...> ;American Journal of Hematology. 2024 May 1
• 8 citations
  CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.
  Jess, J., Yates, B., Dulau-Florea, A., Parker, K., Inglefield, J., Lichtenstein, D., Schischlik, F., Ongkeko, M., Wang, Y., Shahani, S., Cullinane, A., Smith, H., Kane...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 4 citations
  High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Phila...
  Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Pourhassan, Vaibhav Agrawal, Paul Koller, Shukaib Arslan, Vanina Tomas...> ;American Journal of Hematology. 2023 Jun 1
• 55 citations
  CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
  Haneen Shalabi, Haiying Qin, Angela Su, Bonnie Yates, Pamela L Wolters, Seth M Steinberg, John A Ligon, Sara Silbert, Kniya DéDé, Mehdi Benzaoui, Sophia Goldberg, Soor...> ;Blood. 2022 Aug 4
• 2 citations
  Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care.
  Shilpa A Shahani, Erin L Marcotte> ;Frontiers in Pediatrics. 2022 Jan 1
• 24 citations
  Infectious Complications of CAR T-Cell Therapy Across Novel Antigen Targets in the first 30 days.
  Lekha Mikkilineni, Bonnie Yates, Seth M. Steinberg, Shilpa A Shahani, John C Molina, Tara N. Palmore, Daniel W. Lee, Rosandra N. Kaplan, Crystal L. Mackall, Terry J. F...> ;Blood Advances. 2021 Oct 7
• 2 citations
  Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes.
  Ibrahim Aldoss, Raju Pillai, Dongyun Yang, Lixin Yang, Shukaib Arslan, Sally Mokhtari, Monzr M. Al Malki, Amandeep Salhotra, Shilpa A. Shahani, Haris Ali, Matthew Mei,...> ;Blood Cancer Journal. 2021 Jul 2
• 42 citations
  Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
  Erin F. Simonds, Edbert D. Lu, Oscar Badillo, Shokoufeh Karimi, E Liu, Whitney Tamaki, Chiara Rancan, Kira Downey, Jacob Stultz, Meenal Sinha, Lauren K. McHenry, Nicol...> ;Journal for Immunotherapy of Cancer. 2021 Jun 1
• 19 citations
  Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma
  Soheila Shirinbak, Randall Y. Chan, Shilpa Shahani, Sakunthala Muthugounder, Rebekah J. Kennedy, Long T. Hung, G. Esteban Fernandez, Michael D. Hadjidaniel, Babak Mogh...> ;Oncoimmunology. 2021 Jan 4
• 22 citations
  Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia.
  George Mo, Hao-Wei Wang, Aimee C Talleur, Shilpa A Shahani, Bonnie Yates, Haneen Shalabi, Michael G. Douvas, Katherine R. Calvo, Jack F. Shern, Sridhar Chaganti, Katha...> ;Journal for Immunotherapy of Cancer. 2020 Nov 1
• 48 citations
  Updates on CAR T-cell therapy in B-cell malignancies.
  Elad Jacoby, Shilpa A Shahani, Nirali N. Shah> ;Immunological Reviews. 2019 Jul 1
• 2 citations
  Attention deficit hyperactivity disorder screening electrocardiograms: a community-based perspective.
  Shilpa A. Shahani, William N. Evans, G. A. Mayman, Vincent C. Thomas> ;Pediatric Cardiology. 2014 Mar 1
• Join now to see all